Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains ...

For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly ...

At the American Urological Association (AUA) that starts later this week, J&J is scheduled to report that TAR-200 achieved a ...

Sky Labs' CART-I ring – described as a cardio tracker – achieved 84.6% sensitivity compared to 69.1% for the Apple Watch, ...

The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies for rare and common diseases. With momentum building from ...

This July, the 13 th Tumor Models Summit Boston returns, uniting 180+ preclinical and translational experts from biopharma ...

Roche's decision to invest heavily in the US – along with Novartis' announcement, has come hard on the heels of European ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. Ben ...

To encourage the uptake of complex therapies in clinical practice, brand teams must ensure they use data-driven insights to understand the needs and preferences of healthcare professionals (HCPs ...

Evolution and innovation are critical to the field of life sciences, with each year bringing new challenges and breakthroughs. This holds especially true in the built environment — the labs ...

The life sciences industry is constantly evolving. With tight budgets, shifting priorities, and the way we work changing for good, life sciences companies need to keep pace with employee and ...